O’Reilly, C., Mills, S., Rea, M. C., Lavelle, A., Ghosh, S., Hill, C., & Ross, R. P. (2023). Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches. Microbiome Res Rep.

O’Reilly, Catherine, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, and R. Paul Ross. "Interplay between Inflammatory Bowel Disease Therapeutics and the Gut Microbiome Reveals Opportunities for Novel Treatment Approaches." Microbiome Res Rep 2023.

O’Reilly, Catherine, et al. "Interplay between Inflammatory Bowel Disease Therapeutics and the Gut Microbiome Reveals Opportunities for Novel Treatment Approaches." Microbiome Res Rep 2023.